-

The Law Offices of Frank R. Cruz Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Avid Bioservices, Inc. (“Avid” or the “Company”) (NASDAQ: CDMO) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On March 6, 2024, Avid disclosed that it had received an acceleration notice from a holder of its 1.250% Exchangeable Senior Notes due 2026. The holder further claimed that the accelerated amount, inclusive of principal and interest due and payable, as of February 29, 2024, the date of acceleration, was approximately $146.0 million and accrues interest at 2.75% per annum until paid in full. The Company also disclosed that it may be unable to timely file its first quarter 2024 financial results.

On this news, Avid’s stock price fell $2.69, or 30.6%, to close at $6.10 per share on March 7, 2024, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Avid securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

Law Offices of Frank R. Cruz

NASDAQ:CDMO

Release Versions

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

More News From Law Offices of Frank R. Cruz

Securities Fraud Lawsuit Filed Against Tenax Therapeutics, Inc.: The Law Offices of Frank R. Cruz Outlines Lead Plaintiff Deadline

LOS ANGELES--(BUSINESS WIRE)--A securities class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) on behalf of investors who purchased or otherwise acquired Tenax Therapeutics, Inc. securities from November 13, 2023 to August 7, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Katz v. Tenax Therapeutics, Inc. et al., filed on October 26, 2026 in the U.S. District Court North Carolina Middle District (Case No. 1:26-...

Securities Fraud Lawsuit Filed Against Everest Group, Ltd.: The Law Offices of Frank R. Cruz Outlines Lead Plaintiff Deadline

LOS ANGELES--(BUSINESS WIRE)--A securities class action lawsuit has been filed against Everest Group, Ltd. ("Everest" or the "Company") (NYSE: EG) on behalf of investors who purchased or otherwise acquired Everest Group, Ltd. securities from February 8, 2024 to October 27, 2025, inclusive. The Law Offices of Frank R. Cruz today reported the case, City of Detroit General Retirement System, et al. v. Everest Group, Ltd., et al., filed on October 28, 2026 in the U.S. District Court New York Souther...

Lost Money on Arbor Realty Trust, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 29.14% Stock Decline

LOS ANGELES--(BUSINESS WIRE)--Arbor Realty Trust, Inc. ("Arbor" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Arbor Realty Trust, Inc. (NYSE: ABR), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Arbor Realty Trust, Inc. on October 30, 2026.If you lost m...
Back to Newsroom